Cancers | Free Full-Text | Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors | HTML
A decade of clinical development of PARP inhibitors in perspective - Annals of Oncology
Role of PARP Inhibitors in BRCA-Related Malignancies
FDA Approves Olaparib, Rucaparib to Treat Prostate Cancer - National Cancer Institute
Dual mechanism of action of PARPi. Notes: Olaparib inhibits parylation... | Download Scientific Diagram
![PDF] Olaparib in the management of ovarian cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ad254fed2cb3cd498ac267fc52df962f4bacc6f0/3-Figure1-1.png "PDF] Olaparib in the management of ovarian cancer | Semantic Scholar")
PDF] Olaparib in the management of ovarian cancer | Semantic Scholar
BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression | Scientific Reports
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
Olaparib - Wikipedia
Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: | DDDT
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells - ScienceDirect
PARP Inhibition: A New Approach To Cancer Therapy? Dr. Geert Kolvenbag - ppt download
PARP Inhibitors: Where Are We in 2020 and What's Coming Next?
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance | Experimental & Molecular Medicine
PARP inhibitors in cancer treatment | OncologyPRO
Lynparza (olaparib) for the Treatment of BRCA-mutated Advanced Ovarian Cancer - Clinical Trials Arena
Mechanism of action of PARP (poly-ADP-ribose-polymerase). Single strand... | Download Scientific Diagram
Lynparza recommended for approval in ovarian cancer | Cambridge Network
Olaparib
Olaparib mechanism, specifically in BRCA-deficient cells compared to... | Download Scientific Diagram
Frontiers | PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance | Cell and Developmental Biology
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance | Experimental & Molecular Medicine
Mechanism of sensitivity to PARP inhibition in BRCA-deficient cells SSB | Download Scientific Diagram
Therapeutic applications of PARP inhibitors in ovarian cancer - ScienceDirect
